A PMC-published clinical framework proposes three phases for structuring the combination of GLP-1 therapy and intermittent fasting
Behavior change takes belief
While the mechanism is not fully understood, BPC-157 appears to influence dopamine and serotonin systems in ways that may counteract some of the mood changes that occasionally accompany significant dietary restriction
Mounjaro prescribing and medication information
Appetite Control and Weight Loss : By modulating appetite-regulating centers in the brain, GLP-1 R enhances satiety , reduces food intake , and supports weight management , making it a valuable peptide for obesity research
Patients should be monitored for signs of malnutrition, particularly protein deficiency, and may benefit from nutritional counseling to ensure adequate intake of essential nutrients